Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that all patients in the ongoing Phase III study for the drug candidate AKP02G2 have been ...

It ensures that there is minimal melanin absorption, and without tissue affecting the surroundings. It is excellent for those of Fitzpatrick skin types IV-VI as they are given a safe solution to their ...